AZ Vaccine Safety Review To Give Rapid Answer- But No Guarantee Of EU Consensus
Germany Records Rare Brain Bloodclots
Executive Summary
Member states do not have to follow European Medicines Agency guidance – which means division and confusion could persist after it issues its verdict on the safety of the AstraZeneca vaccine.
You may also be interested in...
Real-World Evidence On COVID 19 Vaccines Coming Into US FDA
Peter Marks says agency is getting first RWE readouts of vaccine safety; AstraZeneca’s vaccine has no expiration date, so stockpile is not currently at risk of being thrown out, the CBER director tells a House hearing.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Corbus And Janux Lead Q1’s Small-Cap Winners
Corbus has presence in both antibody drug conjugates and obesity, and was the stand-out small-cap target for investors with a fivefold increase in its share price in Q1.